Chagas Disease-induced Sudden Cardiac Arrest

Overview

Journal Clin Pract Cases Emerg Med

Specialty Emergency Medicine

Date 2018 Jun 1

PMID 29849341

Citations 2

Authors

Michael M Neeki

Michelle Park

Karan Sandhu

Kathryn Seiler

Jake Toy

Massoud Rabiei

Sasikanth Adigoupula

Affiliations

Soon will be listed here.

Abstract

Sudden cardiac death (SCD) is the most common cause of death in patients with Chagas disease (ChD). There are over 300,000 ChD-infected individuals living in the United States, of whom 10-15% have undiagnosed Chagas cardiomyopathy (CCM). CCM patients have a higher risk of SCD compared to non-CCM patients, although early and appropriate treatment of CCM patients can result in a 95% relative risk reduction of SCD. Emergency physicians have a unique opportunity to improve outcomes among these patients by becoming more vigilant in recognizing the signs and symptoms of CCM in patients who present in sudden cardiac arrest. We report the case of a patient presenting to the emergency department with pulseless ventricular tachycardia and an undiagnosed history of CCM.

Citing Articles

Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy.

Malcolm E, Saunders A, Vitt J, Boutet B, Hamer S J Vet Intern Med. 2022; 36(3):1100-1105.

PMID: 35388923 PMC: 9151465. DOI: 10.1111/jvim.16422.

Discovery of Potent -Ethylurea Pyrazole Derivatives as Dual Inhibitors of and .

Varghese S, Rahmani R, Russell S, Deora G, Ferrins L, Toynton A ACS Med Chem Lett. 2020; 11(3):278-285.

PMID: 32184957 PMC: 7073874. DOI: 10.1021/acsmedchemlett.9b00218.

References

do Brasil P, Xavier S, Holanda M, Hasslocher-Moreno A, Braga J . Does my patient have chronic Chagas disease? Development and temporal validation of a diagnostic risk score. Rev Soc Bras Med Trop. 2016; 49(3):329-40. DOI: 10.1590/0037-8682-0196-2016. View

Conners E, Vinetz J, Weeks J, Brouwer K . A global systematic review of Chagas disease prevalence among migrants. Acta Trop. 2016; 156:68-78. PMC: 5155706. DOI: 10.1016/j.actatropica.2016.01.002. View

Traina M, Sanchez D, Hernandez S, Bradfield J, Labedi M, Ngab T . Prevalence and Impact of Chagas Disease Among Latin American Immigrants With Nonischemic Cardiomyopathy in Los Angeles, California. Circ Heart Fail. 2015; 8(5):938-43. PMC: 10108371. DOI: 10.1161/CIRCHEARTFAILURE.115.002229. View

Pinto A, Valente S, Valente V . Emerging acute Chagas disease in Amazonian Brazil: case reports with serious cardiac involvement. Braz J Infect Dis. 2005; 8(6):454-60. DOI: 10.1590/s1413-86702004000600010. View

Marin-Neto J, Rassi Jr A, Avezum Jr A, Mattos A, Rassi A, Morillo C . The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:319-24. DOI: 10.1590/s0074-02762009000900042. View

Punukollu G, Gowda R, Khan I, Navarro V, Vasavada B . Clinical aspects of the Chagas' heart disease. Int J Cardiol. 2006; 115(3):279-83. DOI: 10.1016/j.ijcard.2006.03.004. View

Hsu R, Burak J, Tiwari S, Chakraborti C, Sander G . Chagas Cardiomyopathy in New Orleans and the Southeastern United States. Ochsner J. 2016; 16(3):304-8. PMC: 5024814. View

Gascon J, Albajar P, Canas E, Flores M, Gomez I Prat J, Herrera R . [Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic]. Rev Esp Cardiol. 2007; 60(3):285-93. View

Bern C, Montgomery S . An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009; 49(5):e52-4. DOI: 10.1086/605091. View

10.

Rassi Jr A, Rassi A, Little W, Xavier S, Rassi S, Rassi A . Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med. 2006; 355(8):799-808. DOI: 10.1056/NEJMoa053241. View

11.

Andrade D, Gollob K, Dutra W . Acute chagas disease: new global challenges for an old neglected disease. PLoS Negl Trop Dis. 2014; 8(7):e3010. PMC: 4117453. DOI: 10.1371/journal.pntd.0003010. View

12.

Viotti R, Alarcon de Noya B, Araujo-Jorge T, Grijalva M, Guhl F, Lopez M . Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother. 2013; 58(2):635-9. PMC: 3910900. DOI: 10.1128/AAC.01662-13. View

13.

Martinelli M, de Siqueira S, Sternick E, Rassi Jr A, Costa R, Ramires J . Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease. Am J Cardiol. 2012; 110(7):1040-5. DOI: 10.1016/j.amjcard.2012.05.040. View

14.

Liechti M, Baur H, GURTNER H, STRAUB P . [Cardiac complications of American trypanosomiasis (Chagas disease). Various case reports and general observations]. Schweiz Med Wochenschr. 1990; 120(41):1493-6. View

15.

Stimpert K, Montgomery S . Physician awareness of Chagas disease, USA. Emerg Infect Dis. 2010; 16(5):871-2. PMC: 2953998. DOI: 10.3201/eid1605.091440. View

16.

Morillo C, Marin-Neto J, Avezum A, Sosa-Estani S, Rassi Jr A, Rosas F . Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy. N Engl J Med. 2015; 373(14):1295-306. DOI: 10.1056/NEJMoa1507574. View

17.

Manne-Goehler J, Reich M, Wirtz V . Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg. 2015; 93(1):108-13. PMC: 4497880. DOI: 10.4269/ajtmh.14-0826. View

18.

Bimbi B, Unger P, Vandenbossche J, Silance P, Van Laethem Y . Chagas disease: don't forget it in Latin American patients with heart block!. Acta Cardiol. 2014; 69(2):206-8. DOI: 10.1080/ac.69.2.3017306. View

19.

Barbosa M, Carmo A, da Costa Rocha M, Ribeiro A . Ventricular arrhythmias in Chagas disease. Rev Soc Bras Med Trop. 2015; 48(1):4-10. DOI: 10.1590/0037-8682-0003-2014. View

20.

de Souza A, Salles G, Hasslocher-Moreno A, Silvestre de Sousa A, do Brasil P, Magalhaes Saraiva R . Development of a risk score to predict sudden death in patients with Chaga's heart disease. Int J Cardiol. 2015; 187:700-4. DOI: 10.1016/j.ijcard.2015.03.372. View